Cyclerion Therapeutics, Inc. today announced that it has entered into a licensing agreement with the Massachusetts Institute of Technology ("MIT”), securing the intellectual property that will serve ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback